|
“Discovery is not limited by expertise, but by the barriers preventing
experts from connecting and collaborating with their contemporaries,
investors, and the communities they benefit. CureNeuro aims
to remove these barriers and accelerate the discovery of new
platforms that more effectively address human health care
needs.”
-Douglas McCartney, Director, Science,
Innovation & Business Development Division, Manitoba Science
& Technology
"The NeuroNet's innovative micro-venture philanthropy system
enables patients to collectively fund the research that they
believe will have the most promising outcome and represents
a powerful new way to support cutting edge research for brain
diseases."
-Zack Lynch, Founder and Executive Director,
Neurotechnology Industry Organization
"CureNeuro has a unique concept in allowing researchers
working on different diseases to interact and share ideas
in an open, collaborative forum. These open discussions may
accelerate developments in understanding diseases and finding
therapies in a way not possible in other contexts."
-Catherine Lomen-Hoerth, M.D., Ph.D.,
Director of the ALS Center, UCSF
|
The NeuroNet
The NeuroNet is an internet based research
and funding network specifically designed to address structural
communication and funding challenges in the development of treatments
and cures for neurological diseases. It does this by:
- Providing a private and secure environment in which researchers
can freely collaborate and exchange ideas at all stages
of their work
- Aligning researchers with investors who have a specific
interest in the types of research they are conducting
- Empowering patients and individuals whose lives have
been affected by neurological diseases to get directly involved-at
any level- by choosing to support areas of research that
they believe will have the greatest impact
Researchers will gain access to vast real-time feedback and
collaborative networks at a rate and depth heretofore unrealized
while spending less time and energy seeking funding –
thereby expediting the process of eradicating debilitating
diseases like Alzheimer’s, ALS, Huntington’s,
MS, Parkinson’s, and hundreds of variants.
While the NeuroNet utilizes the well known open source principles
of collaboration, transparency and accessibility, its structure
is unique, simultaneously providing a private and secure environment
for idea exchange and access to diverse funding opportunities.
Researchers, funders, clinicians and other stakeholders can
interact with various degrees of security and information
sharing depending on their interest in specific subject matter,
time commitment and professional role. Even a basic level
of participation connects stakeholders with the most relevant
peer group in the world to immediately aggregate and process
their work.
Importantly, the inclusion of microfinance options for investors
increases the likelihood of participation by private citizens,
thereby increasing funding possibilities for researchers and
providing new avenues for individuals interested in supporting
neurological research.
For more
information on the NeuroNet, click here
|
“The NeuroNet embraces the international
community of those afflicted with a neurological disorder and
medical researchers. Putting the two together empowers patients
and speeds researchers in their quest for a cure.” -Andrew
N. Wilner, MD, FACP, FAAN, author of Epilepsy:
199 Answers
"CureNeuro has a great plan to leverage the collaborative
mindshare of thousands of researchers, funders, clinicians and
patients through an elegant online communication platform. These
efforts will hopefully break down existing barriers, and serve
as a catalyst for more outcome-driven research, designed to
speed time to drug discovery and bring treatments to those who
suffer from diseases for which there are no effective treatments
or cures."
-Ken Toren, Executive Director, The
Parkinson’s Institute
"Neurological diseases face a partially daunting challenge
in moving from an initial idea to a new therapeutic. Involving
patients and the disease community in a transparent open system
is probably the most important thing we can do to help accelerate
the process as patients force the illumination of value into
an otherwise unaligned system."
-Jamie Heywood, Chairman,
PatientsLikeMe, d'Arbeloff Founding Director, ALS Therapy
Development Institute
|
